| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 103 |
| 1 | TACROLIMUS | 96 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 93 |
| 3 | TACROLIMUS OINTMENT 0.1% | 93 |
| 4 | MYCOPHENOLATE MOFETIL | 73 |
| 5 | METHYLPREDNISOLONE | 66 |
| 6 | PREDNISOLONE | 66 |
| 7 | PREDNISOLONE ORAL | 66 |
| 8 | PREDNISOLONE ORAL SOLUTION | 66 |
| 9 | FUROSEMIDE | 61 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CITRIC ACID, GLUCONOLACTONE AND MAGNESIUM CARBONATE | 1 | 0.0588 |
| 1 | DIBUCAINE 1% | 1 | 0.0087 |
| 2 | AMPICILLIN AND SULBACTAM | 7 | 0.0080 |
| 3 | SORBITOL | 4 | 0.0066 |
| 4 | ANORECTAL OINTMENT | 1 | 0.0046 |
| 5 | BENZOCAINE AND DEXTROMETHORPHAN HYDROBROMIDE | 1 | 0.0040 |
| 6 | BENZOCAINE AND MENTHOL | 1 | 0.0038 |
| 7 | BETAXOLOL | 3 | 0.0037 |
| 8 | ACETIC ACID | 1 | 0.0028 |
| 9 | AMPICILLIN SODIUM AND SULBACTAM SODIUM | 7 | 0.0027 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 245 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 80 |
| 2 | Proton Pump Inhibitor [EPC] | 71 |
| 3 | Loop Diuretic [EPC] | 65 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 61 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 59 |
| 6 | Azole Antifungal [EPC] | 46 |
| 7 | Benzodiazepine [EPC] | 43 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 42 |
| 9 | Platinum-based Drug [EPC] | 39 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 34 | 0.0015 |
| 1 | Antimalarial [EPC] | 13 | 0.0012 |
| 2 | Antiprotozoal [EPC] | 13 | 0.0012 |
| 3 | Lipid-based Polyene Antifungal [EPC] | 11 | 0.0009 |
| 4 | Echinocandin Antifungal [EPC] | 7 | 0.0009 |
| 5 | Tetracycline-class Antibacterial [EPC] | 6 | 0.0008 |
| 6 | Glinide [EPC] | 5 | 0.0006 |
| 7 | Vitamin D2 Analog [EPC] | 4 | 0.0006 |
| 8 | CD33-directed Immunoconjugate [EPC] | 2 | 0.0005 |
| 9 | Provitamin D2 Compound [EPC] | 16 | 0.0005 |